HemoCleanse, Inc. and Ash Access Technology, Inc. Appoint New Officer   Companies Promote Roland K. Winger to Vice President, Engineering and Quality Assurance
Friday, December 10, 2004 3:30 PM EST - - - Robert B. Truitt, President and CEO of HemoCleanse, Inc. and Ash Access Technology, Inc., both Lafayette, Indiana companies, announced the appointment of Roland K. Winger to the position of Vice President, Engineering and Quality Assurance in both organizations. [ more ]

HemoCleanse, Inc. Receives $1.0 million NIAID Bioterrorism Grant   Funding will Support the Company's Development of a Device to Treat Septicemia Caused by Bacterial Bioterrorism
February 17, 2004 7:52 AM EST - - - The National Institute of Allergy and Infectious Diseases (NIAID) has approved a $1 million, two-year grant submitted by HemoCleanse, Inc. to develop a novel plasmapheresis device designed specifically to treat victims of bioterrorism-induced sepsis. [ more ]

HemoCleanse, Inc. Announces the Spin-Out of Ash Access Technology, Inc.   New Company To Focus on Catheter, and Vascular Access Products
Tuesday, October 23, 2003 7:40 AM EST - - - Today HemoCleanse, Inc., a Lafayette, Indiana developer of extracorporeal and vascular access medical devices, announced the spin-out of its wholly owned subsidiary, Ash Access Technology, Inc., to shareholders. The transaction was made internally on July 1, 2003, and is being announced to the public today. [ more ]

HemoCleanse, Inc. Announces the Formation of HemoCleanse Technologies, LLC   New Company To Focus on Next Generation Liver Dialysis Unit
Tuesday, October 23, 2003 7:41 AM EST - - - Today HemoCleanse Inc., a Lafayette, Indiana developer of extracorporeal and vascular access medical devices, announced the formation of HemoCleanse Technologies, LLC to focus on the development of its next generation liver dialysis unit. [ more ]